Vibrio Vulnificus Infections Expanding Their Range
FRIDAY, March 31, 2023 (HealthDay News) — The opportunistic bacterial pathogen Vibrio vulnificus is projected to expand its current range, and infections may be present in every Eastern U.S. state by 2081 to 2100, according to a study published onlin…
Learn MoreADHD Med Prescriptions Spiked Early in Pandemic
FRIDAY, March 31, 2023 (HealthDay News) — Prescriptions for attention deficit hyperactivity disorder (ADHD) medications spiked during the COVID-19 pandemic, a new government report shows.The trend may reflect both greater awareness among adults of AD…
Learn MoreInitiating Salvage RT When PSA >0.25 ng/mL Linked to All-Cause Mortality
FRIDAY, March 31, 2023 (HealthDay News) — For men with one high-risk factor, initiating post-radical prostatectomy salvage radiation therapy (sRT) when prostate-specific antigen (PSA) levels are greater than 0.25 ng/mL is associated with an increased…
Learn MoreIncidence of Type 1, Type 2 Diabetes Increasing in People Younger Than 20
FRIDAY, March 31, 2023 (HealthDay News) — The incidence of type 1 and type 2 diabetes is increasing among children and young people aged 0 to 19 years, according to a study published in the April issue of The Lancet Diabetes & Endocrinology.Lynne E. …
Learn MoreMemantine Reduces Symptoms of Hair Pulling, Skin Picking
FRIDAY, March 31, 2023 (HealthDay News) — Treatment with the glutamate modulator, memantine, a drug commonly used to treat Alzheimer disease, results in a significant reduction in hair-pulling and skin-picking symptoms, according to a study published…
Learn MoreOral Azithromycin Equivalent to Six Weeks Doxycycline for Meibomian Gland Dysfunction
FRIDAY, March 31, 2023 (HealthDay News) — Three weeks of oral azithromycin seems to be equivalent to six weeks of doxycycline for treatment of severe meibomian gland dysfunction (MGD), according to a study published online March 23 in JAMA Ophthalmol…
Learn MoreSuspicious Mammogram? Out-of-Pocket Costs Keep Some Women From Follow-Up
FRIDAY, March 31, 2023 (HealthDay News) — Breast cancer screening may be free for women with health insurance, but high costs may still keep some from getting needed follow-up tests, a new study finds.The study, of more than 230,000 U.S. women who un…
Learn More